Ensign Peak Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-207,692
Closed -$9.86M 1685
2025
Q3
$9.86M Buy
207,692
+19,283
+10% +$934K 0.02% 460
2025
Q2
$10.1M Buy
188,409
+33,365
+22% +$1.52M 0.02% 470
2025
Q1
$6.28M Hold
155,044
0.01% 579
2024
Q4
$4.31M Hold
155,044
0.01% 685
2024
Q3
$4.45M Sell
155,044
-82,450
-35% -$2.15M 0.01% 661
2024
Q2
$5.57M Buy
237,494
+4,950
+2% +$106K 0.01% 594
2024
Q1
$5.87M Sell
232,544
-720
-0.3% -$17.3K 0.01% 578
2023
Q4
$5.45M Buy
233,264
+650
+0.3% +$12.8K 0.01% 607
2023
Q3
$11.8M Buy
232,614
+55,000
+31% +$2.56M 0.03% 347
2023
Q2
$8.29M Buy
177,614
+2,050
+1% +$93.9K 0.02% 470
2023
Q1
$6.72M Buy
175,564
+12,300
+8% +$548K 0.01% 493
2022
Q4
$8.95M Sell
163,264
-6,770
-4% -$290K 0.02% 439
2022
Q3
$5.79M Buy
170,034
+98,543
+138% +$1.51M 0.01% 490
2022
Q2
$676K Buy
71,491
+46,206
+183% +$482K ﹤0.01% 1317
2022
Q1
$359K Hold
25,285
﹤0.01% 1688
2021
Q4
$535K Hold
25,285
﹤0.01% 1603
2021
Q3
$565K Hold
25,285
﹤0.01% 1597
2021
Q2
$628K Hold
25,285
﹤0.01% 1548
2021
Q1
$733K Hold
25,285
﹤0.01% 1518
2020
Q4
$652K Buy
25,285
+5,964
+31% +$166K ﹤0.01% 1543
2020
Q3
$595K Sell
19,321
-7,881
-29% -$275K ﹤0.01% 1485
2020
Q2
$678K Buy
27,202
+11,933
+78% +$273K ﹤0.01% 1400
2020
Q1
$324K Sell
15,269
-8,554
-36% -$183K ﹤0.01% 1472
2019
Q4
$529K Buy
+23,823
New +$493K ﹤0.01% 1499

Other funds holding AKRO